Know the Prices

The price of the specialty generics that threaten to capture your market share might be almost the same as yours.

A Wall Street Journal analysis of pricing data found that CVS and Cigna were charging 24x higher for these drugs than what drugmakers charge; UnitedHealth Group’s prices were 3.5x as much.

For example, the cancer drug Gleevec went generic in 2016 and can be bought today for as little as $55/month. CVS Health and Cigna can charge ≥$6,600/month because they set the prices with their in-house pharmacies.

How much are patients paying for the specialty generics that you’re up against? As important: how much are patients paying for your product? If you don’t uncover this, who will?